Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer
Article in Journal for ImmunoTherapy of Cancer (March 2022)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in Journal for ImmunoTherapy of Cancer (March 2022)
Article in European Archives of Oto-Rhino-Laryngology (August 2019)
Article in Frontiers in Oncology (January 2019)